The Spanish Society of Medical Oncology: objectives, structure and history

Similar documents
WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

LEBANON. WCPT COUNTRY PROFILE December 2018

Where we stand in EFORT

DENMARK. WCPT COUNTRY PROFILE December 2018

GERMANY. WCPT COUNTRY PROFILE December 2018

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

European Collaboration on Dementia. Luxembourg, 13 December 2006

Smokefree Policies in Europe: Are we there yet?

European status report on alcohol and health Leadership, awareness and commitment

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Alcohol-related harm in Europe and the WHO policy response

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Overall survival: 1 st line therapy

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Q1 What age are you?

European Status report on Alcohol and Health

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Alcohol Prevention Day

Table 6.1 Summary information for colorectal cancer in Ireland,

The health economic landscape of cancer in Europe

Palliative nursing care of children and young people across Europe

European Community Pharmacy: a reference in Public Health

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Europa Donna in Europe and in Slovenia

Table 7.1 Summary information for lung cancer in Ireland,

Table 9.1 Summary information for stomach cancer in Ireland,

Cross Border Genetic Testing for Rare Diseases

The Identification of Food Safety Priorities using the Delphi Technique

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

Project Meeting Prague

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

European Association of Dental Public Health Prevention of Oral Cancer

Sign Language Act in Europe and Hungary by dr. Ádám Kósa

A European vision of CPD including specialisation An interim report

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

FORUM FOR AEROSPACE NDT BOARDS

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Joint Programming in Neurodegenerative Disease Research (JPND)

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Monthly measles and rubella monitoring report

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

Pharmacy Ownership and Establishment

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Nutrient profiles for foods bearing claims

Underage drinking in Europe

COMMISSION OF THE EUROPEAN COMMUNITIES

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU

The cancer burden in the European Union and the European Region: the current situation and a way forward

Where do EU Contries set the limit for low risk drinking.

Rheumatoid Arthritis Disease Burden and Access to Treatment

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Prevention of Oral Cancer Special Interest Working Group

Impact of education: challenges and recommendations

The Risk of Alcohol in Europe. Bridging the Gap June 2004

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

EUVAC.NET A surveillance network for vaccine-preventable diseases

Real Life, Real PD Survey

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

Overview of drug-induced deaths in Europe - What does the data tell us?

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

Differences make a Difference

The EHRA White Book 2009 The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Measles and rubella monitoring January 2015

This document is a preview generated by EVS

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

11 Melanoma of the skin

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

UK bowel cancer care outcomes: A comparison with Europe

'SECTION B EU PARTY. The following abbreviations are used:

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

8 th Congress of ECCO

Useful EU information on organ donation and transplantation

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

To provide information on the new standard, a number of EOG members formed a committee to compile information on the following basis:

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

GLP in the European Union Ecolabel detergents, GLP and accreditation

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

Outcome of proficiency test on EIA serology

La Réanimation en Europe

Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

Primary and secondary prevention of sudden cardiac death in emerging economies

Perspectives for information on alcohol use in the EU

Transcription:

The Spanish Society of Medical Oncology: objectives, structure and history The Spanish Society of Medical Oncology (SEOM) brings together Spanish specialists who are dedicated solely to fighting cancer on all fronts: - Primary prevention (not smoking, avoiding obesity, taking physical exercise, eating fruit and vegetables) - Early diagnosis (mammograms, etc.) - Improved diagnosis (better techniques, molecular biology, PET, etc.) - Promoting a multidisciplinary approach to provide comprehensive care for cancer patients throughout the whole course of their illness - Encouraging uniformity of criteria for the treatment of cancer in its various locations and extensions. - Instigating improvements in the treatment of cancer. - Promoting research and Continued Training in order to integrate advancements and to continuously update knowledge. - Lending continuous support for any needs the patients and their families may have. SEOM is the leading organisation for Oncology in Spain and ensures that excellent-quality care is provided by the Medical Oncology Units, by encouraging the study and research of cancer. SEOM is a society which is actively dedicated to informing and educating the various groups with respect to Oncology: the medical sector, health administration, patients, families, the general public, the pharmaceutical industry and the media. Its objectives include promoting the study and research of neoplastic disease and seeking to standardise clinical/therapeutic criteria in its diagnosis and treatment. To this end, SEOM aims, on the one hand, to instigate improvements in the treatment of cancer from a care, research and educational perspective. On the other hand, to promote the multidisciplinary approach in order to provide cancer patients with comprehensive care and to encourage uniformity of criteria for the treatment of cancer in its various locations and extensions. Another of the set objectives is to establish synergy between the activities of the other groups concerned, which include patient associations, scientific societies, although they may not be related specifically to the field of oncology, such as general or family medicine, research centres and international oncology societies. 1 / 5

With regard to the health education of Spanish society on the subject of cancer, SEOM is actively involved in the prevention of this illness, through the promotion of health awareness initiatives aimed at the general public and projects in support of cancer patients. SEOM considers it essential to emphasise the importance of the primary prevention of cancer, early diagnosis and the role of the Genetic Advice Units where help can be given to families who are susceptible to cancer. Furthermore, SEOM contributes towards educating, informing and supporting cancer patients and their families. SEOM is committed to those suffering from cancer during all phases of their illness, also after the medical treatment has finished. SEOM promotes the importance of excellent care for cancer patients. Continued education activities are supported and carried out, both in terms of public and private entities, to ensure that medical oncologists are kept up to date with the latest therapeutic developments. In addition, it supports the production of clinical guides for the diagnosis and treatment of the most common tumours. With regard to clinical research, SEOM considers it essential to promote this area, ensuring that the time required by administration to authorise clinical trials is competitive. We have top professionals who form Cooperative Research Groups for the various types of cancer: TTD (digestive tract), GEICAM (breast), GECP (lung), etc. These Groups constitute a highly useful and valuable tool for clinical and applied cancer research. They are recognised internationally and are used to collaborate on national and international training and research projects. At SEOM we are striving to promote research in hospitals and to bring basic research closer to clinical research, providing them with more structural and economic resources and demanding official status and recognition from the Health Authorities. All of this is aimed at achieving excellent progress in translational research. The work carried out by medical oncologists in Spain has enabled us to reach the highest level in terms of science and care, which is respected by the rest of the world of oncology. This 2 / 5

results in an increase in cure rates and life expectancy for most cancers which have received a coordinated treatment thanks to the comprehensive role the medical oncologist plays in the strategy applied to the disease. Furthermore, at SEOM we have encouraged the relationship between the Medical Oncology Units and the Basic Research Institutions, within or outside of the thematic networks of cooperative research, in order to obtain greater synergy in translational research. Structure SEOM has an internal structure which manages and organises the activities of the Society. We have a Manager, who is responsible for the smooth running of SEOM; a Conventions Department which organises the scientific meetings we hold; a Communications Department responsible for press relations and promoting institutional and public relations activities which help to enhance the public image of SEOM; a technical secretariat and a scientific secretariat, the latter consisting of medical oncologists, members of SEOM. With this structure, SEOM is a scientific society which is strengthening its position day by day as a benchmark scientifically qualified in the field of oncology to which central and regional Health Authorities, other scientific societies, the media and the general public can refer. All this is the fruit of the efforts invested by the whole team and by the 850 members who with their work make it possible for SEOM to be one of the most active scientific societies. SEOM increases its membership daily. In September 2006 we have 850 specialists, most of whom are medical oncologists, but there are also a large number of radiotherapists, as well as geneticists and psycho-oncologists. SEOM strives on a daily basis to improve the services it provides to its members and to offer new services with the desire to facilitate the development of their professional practice. The main services offered by the Society are listed below: - Free legal advice - Professional training service - Updating and publication of the SEOM Directory - Production and delivery of newsletters (SEOM Newsletter) 3 / 5

- Production and distribution of activities report - Production and distribution of manuals, clinical guides and consensus documents - Website ( www.seom.org ) - Free delivery of the journal Seminars in Oncology in Spanish - Free access to several scientific journals of national and international importance - Advice on organising events and on communication and protocol. History and background Over the 36 years in which SEOM has been in existence, each of its presidents has worked towards improving the Society on a day-to-day basis until it has become one of the most active and high-profile scientific societies, both nationally and internationally. In 1970, the first Spanish scientific society relating to cancer was established. It was the Spanish Society of Oncology (SEO); a multidisciplinary society which brought together doctors from all specialities and also those with no speciality (pathologists, radiotherapists, surgeons, internists, etc.). In 1976, the Spanish Society of Chemotherapy (SEQUIO) was founded and as of 1981, with the speciality of Medical Oncology then officially recognised, it changed its name to the Spanish Society of Medical Oncology (SEOM). This aimed to bring together all doctors interested in the medical treatment of cancer. Medical Oncology did not exist as a speciality at that point in Spain. Its definition had been formed in 1972 in the United States and this speciality model was used as a reference in an attempt to create a branch of Medical Oncology within the SEO. However, this initiative was not very well received by other specialities, as the concept of Clinical Oncology, as it was then called, was very vague, being a multidisciplinary speciality which advocated that therapeutic decisions be taken through the clinical oncologist in a merely coordinating role. It was from there that the SEQUIO was established, which from the outset, and particularly following the publication in 1978 of the decree of specialities, fought for the creation and recognition of the speciality of Medical Oncology and not Clinical Oncology. 4 / 5

Spain was the first European country to establish the speciality of Medical Oncology and this step set an example for the rest of Europe. When the European Society for Medical Oncology (ESMO) was founded, Spain was the only country in which the speciality existed as such. ESMO then put pressure on the governments in other countries to establish the speciality, which now exists in the following European countries: Austria, Bosnia-Herzegovina, Croatia, Cyprus, the Czech Republic, France, Georgia, Germany, Greece, Holland, Hungary, Iceland, Italy, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, Switzerland and the United Kingdom. 5 / 5